This page links to other pages with information on drugs in various stages of clinical trials. If you have any information that you would like to share with the community, please add your knowledge on the page for the appropriate drug. As always, patients are advised to seek the advice of their GIST specialist when determining which clinical trials are best suited for their individual needs.
Inhibitors of KIT, PDGRF and VEGF
- Nilotinib (Tasigna) - formerly AMN107.
- Sorafenib (Nexavar) - formerly BAY 43-9006
- Dasatinib (Sprycel) - formerly BMS-354825
HSP90 (Heat Shock Protein 90) Inhibitors
PI3K Inhibitor plus Gleevec
Drugs in Combination
New Trial Drugs / New Ideas / Miscellaneous
- NVP-AEW541 oral tyrosine kinase inhibitor to address the involvement of IGF-1R in wild type gist.